CD95 and TRAF2 promote invasiveness of pancreatic cancer cells.
about
The role of CD95 and CD95 ligand in cancerGrowth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2.CDCOCA: a statistical method to define complexity dependence of co-occuring chromosomal aberrations.Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicityLY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancerConstitutional tandem duplication of 9q34 that truncates EHMT1 in a child with ganglioglioma.Fas Signaling Promotes Gastric Cancer Metastasis through STAT3-Dependent Upregulation of FascinTumor necrosis factor receptor-associated factor family protein 2 is a key mediator of the epidermal growth factor-induced ribosomal S6 kinase 2/cAMP-responsive element-binding protein/Fos protein signaling pathway.Apoptotic pathways in pancreatic ductal adenocarcinomaRole of CYB5A in pancreatic cancer prognosis and autophagy modulationControl of Apoptosis in Treatment and Biology of Pancreatic Cancer.Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer.Neutralization of the CD95 ligand by APG101 inhibits invasion of glioma cells in vitro.c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells.The 'N-factors' in pancreatic cancer: functional relevance of NF-κB, NFAT and Nrf2 in pancreatic cancer.Respiratory syncytial virus-mediated NF-kappa B p65 phosphorylation at serine 536 is dependent on RIG-I, TRAF6, and IKK beta.DICE: A novel tumor surveillance mechanism-a new therapy for cancer?CD95 Signaling Inhibits B Cell Receptor-Mediated Gammaherpesvirus Replication in Apoptosis-Resistant B Lymphoma Cells.DR5 suppression induces sphingosine-1-phosphate-dependent TRAF2 polyubiquitination, leading to activation of JNK/AP-1 and promotion of cancer cell invasion.Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy.Integrated analysis of tumor differentiation genes in pancreatic adenocarcinoma.Genetic Alterations of TRAF Proteins in Human Cancers
P2860
Q26995847-F1D104F8-5A1A-45D8-AC1B-961C16B65A2CQ33369696-1204AC92-7D76-4E25-8A65-B9652A551B74Q33836308-9A11D7BB-C97C-4102-88FE-FAE7C3A15A26Q34542594-46500D2B-91DD-48B0-94DC-9C66543A380EQ34935319-203964FB-F999-4B2A-9788-D0F2B633D758Q35370365-8A782684-0B19-4791-B308-BEA4AAB7AC88Q35448951-369E5F16-0047-436F-A4BF-1E74D3595513Q35620662-2C5D0E7D-E46D-40DD-ADA3-F1F3559FC306Q36122105-69182180-9378-4819-8460-95DEB85756E8Q36835642-B16A1D4F-BD5A-44BA-94E2-356627485B6BQ37532658-B4B0442D-3946-44A1-ABF8-A8114489ED50Q38553219-00A7B330-DB27-4842-8F08-5FF923A09633Q38815842-9B65225A-B577-4100-AE0F-00A5DEBAE9F4Q38889908-7EB824E3-224A-451A-B315-1DEF1E4626EEQ38949421-63C9595D-2A85-453F-88AA-8CD43D4F2380Q39670791-49272723-B9E0-4547-B815-168F7B671D03Q39712150-1F3323F3-D7B6-4F7F-A308-2701C4ED789DQ40464867-E35FBF75-E48D-4EE9-AE99-F2E90A7A9077Q40563964-FCAA41B2-5DED-44CA-BF4D-1EDCFDD2DA21Q42283261-0F9EDD62-0AE3-45F2-A333-9EE48F989D3FQ51760860-F49FDADA-5D5E-4E3B-9D4F-559D78A1D164Q52723252-4F75AB0C-4E26-40D1-B52A-04AFFFDC2DCCQ57191736-D2A5E2C6-F9CC-4C6A-9CA8-9FA450248EA9
P2860
CD95 and TRAF2 promote invasiveness of pancreatic cancer cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
CD95 and TRAF2 promote invasiveness of pancreatic cancer cells.
@en
type
label
CD95 and TRAF2 promote invasiveness of pancreatic cancer cells.
@en
prefLabel
CD95 and TRAF2 promote invasiveness of pancreatic cancer cells.
@en
P2093
P50
P356
P1433
P1476
CD95 and TRAF2 promote invasiveness of pancreatic cancer cells.
@en
P2093
Christian Röder
Daniela Siegmund
Holger Kalthoff
Kristin Karsten
Laia Pagerols-Raluy
Ping Jiang
P304
P356
10.1096/FJ.04-2984FJE
P407
P50
P577
2005-01-24T00:00:00Z